239 related articles for article (PubMed ID: 24991536)
1. The role of ubiquitination and sumoylation in diabetic nephropathy.
Gao C; Huang W; Kanasaki K; Xu Y
Biomed Res Int; 2014; 2014():160692. PubMed ID: 24991536
[TBL] [Abstract][Full Text] [Related]
2. The pathological role of the ubiquitination pathway in diabetic nephropathy.
Pontrelli P; Oranger A; Barozzino M; Conserva F; Papale M; Gesualdo L
Minerva Med; 2018 Feb; 109(1):53-67. PubMed ID: 28974087
[TBL] [Abstract][Full Text] [Related]
3. High glucose induces activation of NF-κB inflammatory signaling through IκBα sumoylation in rat mesangial cells.
Huang W; Xu L; Zhou X; Gao C; Yang M; Chen G; Zhu J; Jiang L; Gan H; Gou F; Feng H; Peng J; Xu Y
Biochem Biophys Res Commun; 2013 Aug; 438(3):568-74. PubMed ID: 23911785
[TBL] [Abstract][Full Text] [Related]
4. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
[TBL] [Abstract][Full Text] [Related]
5. High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy.
Toyoda M; Suzuki D; Honma M; Uehara G; Sakai T; Umezono T; Sakai H
Kidney Int; 2004 Sep; 66(3):1107-14. PubMed ID: 15327405
[TBL] [Abstract][Full Text] [Related]
6. WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling.
Zhou X; Liu Z; Ying K; Wang H; Liu P; Ji X; Chi T; Zou L; Wang S; He Z
Oxid Med Cell Longev; 2020; 2020():7950457. PubMed ID: 32566101
[TBL] [Abstract][Full Text] [Related]
7. Bergenin impedes the generation of extracellular matrix in glomerular mesangial cells and ameliorates diabetic nephropathy in mice by inhibiting oxidative stress via the mTOR/β-TrcP/Nrf2 pathway.
Qiao S; Liu R; Lv C; Miao Y; Yue M; Tao Y; Wei Z; Xia Y; Dai Y
Free Radic Biol Med; 2019 Dec; 145():118-135. PubMed ID: 31494242
[TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome.
Luo ZF; Qi W; Feng B; Mu J; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
Life Sci; 2011 Mar; 88(11-12):512-20. PubMed ID: 21241714
[TBL] [Abstract][Full Text] [Related]
9. MG132 ameliorates kidney lesions by inhibiting the degradation of Smad7 in streptozotocin-induced diabetic nephropathy.
Gao C; Aqie K; Zhu J; Chen G; Xu L; Jiang L; Xu Y
J Diabetes Res; 2014; 2014():918396. PubMed ID: 24511554
[TBL] [Abstract][Full Text] [Related]
10. SP600125 suppresses
Zhang H; Liu X; Zhou S; Jia Y; Li Y; Song Y; Wang J; Wu H
J Mol Endocrinol; 2018 Feb; 60(2):145-157. PubMed ID: 29273684
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
12. Chlorogenic acid prevents diabetic nephropathy by inhibiting oxidative stress and inflammation through modulation of the Nrf2/HO-1 and NF-ĸB pathways.
Bao L; Li J; Zha D; Zhang L; Gao P; Yao T; Wu X
Int Immunopharmacol; 2018 Jan; 54():245-253. PubMed ID: 29161661
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy.
Cheng Y; Zhang J; Guo W; Li F; Sun W; Chen J; Zhang C; Lu X; Tan Y; Feng W; Fu Y; Liu GC; Xu Z; Cai L
Free Radic Biol Med; 2016 Apr; 93():94-109. PubMed ID: 26849944
[TBL] [Abstract][Full Text] [Related]
14. Akebia Saponin D ameliorated kidney injury and exerted anti-inflammatory and anti-apoptotic effects in diabetic nephropathy by activation of NRF2/HO-1 and inhibition of NF-KB pathway.
Lu C; Fan G; Wang D
Int Immunopharmacol; 2020 Jul; 84():106467. PubMed ID: 32344355
[TBL] [Abstract][Full Text] [Related]
15. miR-218 regulates diabetic nephropathy via targeting IKK-β and modulating NK-κB-mediated inflammation.
Li M; Guo Q; Cai H; Wang H; Ma Z; Zhang X
J Cell Physiol; 2020 Apr; 235(4):3362-3371. PubMed ID: 31549412
[TBL] [Abstract][Full Text] [Related]
16. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells.
Huang K; Chen C; Hao J; Huang J; Wang S; Liu P; Huang H
Mol Cell Endocrinol; 2015 Jan; 399():178-89. PubMed ID: 25192797
[TBL] [Abstract][Full Text] [Related]
17. P53/NRF2 mediates SIRT1's protective effect on diabetic nephropathy.
Ma F; Wu J; Jiang Z; Huang W; Jia Y; Sun W; Wu H
Biochim Biophys Acta Mol Cell Res; 2019 Aug; 1866(8):1272-1281. PubMed ID: 30959066
[TBL] [Abstract][Full Text] [Related]
18. NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation.
Luan P; Zhuang J; Zou J; Li H; Shuai P; Xu X; Zhao Y; Kou W; Ji S; Peng A; Xu Y; Su Q; Jian W; Peng W
FASEB J; 2018 Feb; 32(2):1070-1084. PubMed ID: 29070585
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-κB pathway.
Wang H; Huang X; Xu P; Liu X; Zhou Z; Wang F; Li J; Wang Y; Xian X; Liu G; Huang W
Metabolism; 2021 Jun; 119():154740. PubMed ID: 33639183
[TBL] [Abstract][Full Text] [Related]
20. Astaxanthin Promotes Nrf2/ARE Signaling to Inhibit HG-Induced Renal Fibrosis in GMCs.
Xie X; Chen Q; Tao J
Mar Drugs; 2018 Apr; 16(4):. PubMed ID: 29621130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
